The board of directors of Alembic Pharmaceuticals declared a final dividend payout of ₹12.00 per equity share for the fiscal term. This represents a steady percentage increase relative to prior year distributions, reflecting healthy operational profitability and stable cash generation. The designated record date and ex-dividend timeline were established in late July, ensuring eligible shareholders received their payouts directly within standard statutory settlement windows. Income-focused investors track these regular annual distributions as evidence of sound financial health and shareholder-friendly capital allocation policies.